CBD, cannabidiol, etc. The name continues to ring a bell throughout the modern-day. We walk into different grocery stores around the U.S. and see the shelves lined with CBD-based products promising to cure a wide variety of ailments. With so many promises and hopes for the product, what really is CBD and how can it help?
CBD is one of the main cannabinoids or chemical components within the marijuana or hemp plant. With the rise of the Farm Bill, many companies have begun putting CBD into their products in a ploy to breach the health and wellness market. The industry alone is subject to see as much as $5 billion in sales by the end of this year. This marks an almost 700% increase from where the industry was last year. With so much hype, is CBD worth all the news?
What is CBD and Can it Help?
In more detail, CBD is one of the two main cannabinoids within cannabis. The substance is non-psychoactive which means that it cannot get the user high no matter how much they use. This means that it can be a solid alternative for those who cannot get intoxicated. This includes children and the elderly. Combined with the substances massive beneficial compounds, this means that CBD could become a groundbreaking solution for a wide range of illnesses moving into the future.
CBD works by communicating with the endocannabinoid system in the body. The body is able to process the chemical due to its similarities with organic compounds that already exist within us. CB1 receptors, which process the substance in the brain, control cognition, memory, motor skills, pain and much more. If the substance is able to be used in the proper way, it could help to treat and cure a myriad of ailments that we face as a people.
A Marijuana Stock To Buy That Could Benefit From CBD Growth
GW Pharmaceuticals (NASDAQ:GWPH) is a cannabis stock that does not operate in any traditional sense of the industry. This marijuana stock is primarily a pharmaceutical business that has been creating cannabis and CBD infused medicines. This cannabis stock saw a massive amount of upswing due to their approval of the drug Epidiolex.
For those who don’t know, Epidiolex is used to treat rare forms of epilepsy. The drug has been hailed as a miracle substance due to its potential to treat these illnesses when others cannot. Year to date, GW Pharmaceuticals has shot up by as much as 75%, which is quite substantial. GW Pharmaceuticals remains an interesting marijuana stock to watch moving into the near future.
All in all, the CBD market is something that continues to propel itself into the coming years. The hopes are high that as we traverse the coming months, CBD can show how much it really benefits the people. For now, all we have to do is wait and see what happens in terms of legislation and the changing market.